NUP205 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.524600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.706000E-01
Normal-vs-Stage2
5.626800E-01
Normal-vs-Stage3
3.027000E-01
Normal-vs-Stage4
6.040600E-01
Stage1-vs-Stage2
8.279800E-01
Stage1-vs-Stage3
1.865570E-01
Stage1-vs-Stage4
8.472800E-01
Stage2-vs-Stage3
2.014000E-01
Stage2-vs-Stage4
6.613800E-01
Stage3-vs-Stage4
5.855800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.878800E-01
Normal-vs-AfricanAmerican
8.208400E-01
Normal-vs-Asian
2.194000E-01
Caucasian-vs-AfricanAmerican
7.736400E-01
Caucasian-vs-Asian
8.001800E-02
AfricanAmerican-vs-Asian
1.873160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.174400E-01
Normal-vs-Female
6.185800E-01
Male-vs-Female
6.817800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.315000E-01
Normal-vs-Age(41-60Yrs)
8.682600E-01
Normal-vs-Age(61-80Yrs)
4.190200E-01
Normal-vs-Age(81-100Yrs)
8.157800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.750600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.747200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.471800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.510340E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.827000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.458800E-01
Normal-vs-Daily Drinker
4.615600E-01
Normal-vs-Weekly Drinker
6.433400E-01
Normal-vs-Occasional Drinker
8.871800E-01
Normal-vs-Social Drinker
9.341400E-01
Non Drinker-vs-Daily Drinker
8.882000E-01
Non Drinker-vs-Weekly Drinker
7.100600E-01
Non Drinker-vs-Occasional Drinker
1.357420E-01
Non Drinker-vs-Social Drinker
1.682600E-01
Daily Drinker-vs-Weekly Drinker
7.975000E-01
Daily Drinker-vs-Occasional Drinker
1.654980E-01
Daily Drinker-vs-Social Drinker
2.046000E-01
Weekly Drinker-vs-Occasional Drinker
3.969600E-01
Weekly Drinker-vs-Social Drinker
4.325200E-01
Occasional Drinker-vs-Social Drinker
9.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.743200E-01
Normal-vs-Grade 2
9.761000E-01
Normal-vs-Grade 3
9.461200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.729200E-01
Grade 1-vs-Grade 3
1.995590E-01
Grade 1-vs-Grade 4
9.743200E-01
Grade 2-vs-Grade 3
7.003600E-02
Grade 2-vs-Grade 4
9.761000E-01
Grade 3-vs-Grade 4
9.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.549000E-01
Normal-vs-NonDiabetic
5.204000E-01
Diabetic-vs-NonDiabetic
5.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.841800E-01
Normal-vs-NoPancreatitis
5.339400E-01
Pancreatitis-vs-NoPancreatitis
8.281000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.033200E-01
Normal-vs-N1
5.539000E-01
N0-vs-N1
7.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.879200E-01
Normal-vs-TP53-NonMutant
7.034200E-01
TP53-Mutant-vs-TP53-NonMutant
1.847200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
